Dignify Therapeutics, LLC
Publicly observedResearch Triangle Park, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Research Triangle Park | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Dignify Therapeutics, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | LG53EH7JZLK4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant5 Sept 2024Publicly observed
NIH SBIR/STTR award: Novel treatment for urinary incontinence and overactive bladder symptoms in the elderly
USD 110,040.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant1 Mar 2023Publicly observed
NIH SBIR/STTR award: Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
USD 94,793.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant1 Mar 2023Publicly observed
NIH SBIR/STTR award: Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
USD 199,520.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant1 Mar 2023Publicly observed
NIH SBIR/STTR award: Preclinical and Early Clinical Development of a Novel Drug for On-Demand Voiding
USD 976,908.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.